These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1628133)

  • 1. Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective.
    Charak BS; Agah R; Brynes RK; Chogyoji M; Groshen S; Chen SC; Mazumder A
    Bone Marrow Transplant; 1992 Jun; 9(6):479-86. PubMed ID: 1628133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.
    Charak BS; Brynes RK; Katsuda S; Groshen S; Chen SC; Mazumder A
    Cancer Res; 1991 Apr; 51(8):2015-20. PubMed ID: 2009520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.
    Agah R; Malloy B; Kerner M; Girgis E; Bean P; Twomey P; Mazumder A
    Cancer Res; 1989 Nov; 49(21):5959-63. PubMed ID: 2790810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application.
    Charak BS; Areman EM; Dickerson SA; Choudhary GD; Sacher R; Kotula PL; Brown EG; Mazumdar A
    Bone Marrow Transplant; 1993 Feb; 11(2):147-54. PubMed ID: 8435664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 in bone marrow transplantation: preclinical studies.
    Charak BS; Choudhary GD; Tefft M; Mazumder A
    Bone Marrow Transplant; 1992 Aug; 10(2):103-11. PubMed ID: 1326364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.
    Agah R; Malloy B; Kerner M; Mazumder A
    J Immunol; 1989 Nov; 143(9):3093-9. PubMed ID: 2809219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
    Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
    Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft versus leukemia effect after transplantation with interleukin-2-activated bone marrow. Correlation with eradication of residual disease.
    Charak BS; Brynes RK; Chogyoji M; Kortes V; Tefft M; Mazumder A
    Transplantation; 1993 Jul; 56(1):31-7. PubMed ID: 8333064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.
    Charak BS; Malloy B; Agah R; Mazumder A
    Bone Marrow Transplant; 1990 Sep; 6(3):193-8. PubMed ID: 2252959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines transduced bone marrow stromal cell lines promote immunohematopoietic reconstitution in mice after allogeneic bone marrow transplantation.
    Li A; Jiang J; Zhang Q; Hao J; Xie S
    Immunol Lett; 2005 May; 98(2):216-24. PubMed ID: 15860221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
    Verma UN; Bagg A; Brown E; Mazumder A
    Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acceleration of hematopoietic reconstitution in mice transplanted with syngeneic bone marrow cells by IL-6 gene therapy].
    Cai R; Cao X; Ma S
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):97-101. PubMed ID: 9206038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
    Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
    Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model.
    Uharek L; Glass B; Gaska T; Zeiss M; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S57-60. PubMed ID: 8124260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.